M&A Trends: Private Equity And 'Aspirational' Execs Pair Up In India
Executive Summary
Private equity firms partnering with senior management professionals bitten by the entrepreneurial bug to buy pharmaceutical businesses in India were some of the emerging trends highlighted by experts at a recent CPhI congress in Mumbai. Scrip covers the key conference highlights on the "maturing" Indian M&A market, including how foreign firms are shedding their older portfolios to reallocate resources to newer products.
You may also be interested in...
Adcock Divests India Unit But Firm On Low Cost Manufacturing
Adcock Ingram has divested a chunk of its Indian business to the private equity firm, Samara Capital Partners Fund II, having been weighed down by the competitive scene, but it remains upbeat on its low-cost manufacturing venture in the country.
India M&A Trends: Rational Valuations, Foreign Firms Shed Products
Rational valuations and the potential divestment of older portfolios by foreign firms were some of the key mergers and acquisitions (M&A) trends highlighted by industry experts at a recent congress in India.
Dr Reddy's buys UCB portfolio in S Asia
Dr Reddy's Laboratories has snapped up a select portfolio of UCB's established products business in India, Nepal, Sri Lanka and Maldives for INR8bn ($128m), bolstering its presence in the high growth dermatology, respiratory and paediatric segments.